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Available online 2 May 2008A substantial proportion of human genes contain tissue-speciﬁcally DNA-methylated regions (TDMRs).
However, little is known about the evolutionary conservation of differentially methylated loci, how they
evolve, and the signals that regulate them. We have studied TDMR conservation in the PLG and TBX gene
families and in 32 pseudogene–parental gene pairs. Among the members of the recently evolved PLG gene
family, 5′-UTRmethylation is conserved and inversely correlatedwith the cognate gene expression, indicating
as well a conserved regulatory role of DNAmethylation. Conversely, many genes of the much older TBX family
display complementary tissue-speciﬁc methylation, suggesting an epigenetic complementation in the
evolution of this gene family. Similar to gene families, unprocessed pseudogenes arose from gene duplications
and we found TDMR conservation in some pseudogene–parental gene pairs displaying short evolutionary
distances. However, for the majority of unprocessed pseudogenes and for all processed pseudogenes
examined, we found that tissue-speciﬁc methylation arose de novo after gene duplication.
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PseudogenesMammalian DNAmethylation constitutes an important layer of epi-
genetic control and has been implicated in the control and regulation of
tissue-speciﬁc gene expression, gene imprinting, X-chromosomal acti-
vation, and chromosomal integrity (reviewed in [1]). Additionally, aber-
rant methylation and associated tumor suppressor gene silencing and
chromosomal instability have been shown innumerous neoplasias [2,3].
Several recent reports have recognized thewidespreadoccurrence of
tissue-speciﬁc differentially methylated regions (TDMRs) in healthy tis-
sues [4–7]. TDMRs frequently map to the 5′ regions of annotated genes,
but many are located in exon, introns, or intergenic regions. In addition,
differential methylation is not limited to coding genes, but has been
observed in pseudogenes as well [4,8]. Currently, little is known about
how TDMRs evolve and are maintained and the signals that regulate
them. One possibility is that differentiallymethylated locimight bear an
intrinsic genetic or epigenetic signature that triggers differential me-
thylation. Another possibility, not mutually exclusive, is that differential
methylation is the result of other cis- or trans-acting factors or sequences
that regulate the methylation proﬁle of a particular locus. In this regard,
gene duplication events represent a well-suited model to address the
dynamics of (differential) methylation.
Gene duplications are a source of genomic novelties leading to gene
families andunprocessedpseudogenes.Using comparativeanalysis, Lynch
and Conery [9] estimated that gene duplications arise at a high frequency
of about 0.01 per gene permillion years. The classical model by Ohno [10]
predicts that upon geneduplication, one copy retains the original function
under strong surveillance by negative selection, while the other copy
becomes free of selective constraints and evolves mainly in a neutral6761 Hennigsdorf, Germany.
l rights reserved.fashion. Hence, the most likely fate of a new gene duplication event is its
mutational degradation into a pseudogene. However, gene duplication
eventsmay lead aswell to geneswith either a reduced functional capacity
(subfunctionalization) or a new function (neofunctionalization), but little
is known about the mechanisms that prevent degradation into a non-
functional gene. In contrast to unprocessed pseudogenes, which generally
maintain the exon/intron structure of their parental genes, processed
pseudogenes are duplicated genes that arose due to the reverse tran-
scription of the parental gene mRNA and typically lack both regulatory
sequences and an exon/intron structure [11].
Here, we study the dynamics of DNA methylation in three gene
duplication events leading to either functional gene families or unpro-
cessed or processed pseudogenes. We selected two gene families that
differ greatly in their evolutionary age, the ancient TBX family, which
exists in vertebrate and invertebrates, and the more recently evolved
plasminogen precursor (PLG) family, which is present only in the homi-
noid lineage. The unifying feature of the TBX transcription factor family
is the presence of the T domain, which confers DNA binding and dime-
rization. In mammals, 17 distinct genes have been identiﬁed that can be
grouped into ﬁve subfamilies (the T, TBX1, TBX2, TBX6, and Tbr1 sub-
families) based on their evolutionary distance [12]. TBX transcription
factors are crucial in regulating a plethora of processes such as cranio-
facial development, limb outgrowth and patterning, and T cell diffe-
rentiation [12]. The secondgene familywe investigated is thePLG family,
consisting of four known members (PLG, PLGLA, PLGLB1 and PLGLB2).
While the PLG gene itself is located on chromosome 6q25.3 within the
IGF2R imprinting cluster, the three plasminogen-related genes, PLGLA,
PLGLB1 and PLGLB2map to chromosomes 2q12.2, 2p11.2 and 2q11–p11,
respectively [13,14]. PLG encodes plasminogen that circulates in the
plasma as a proenzyme [15] and, in the presence of a ﬁbrin clot, is
converted to plasmin by the tissue plasminogen activator. Upon this
Fig. 1. Tissue-speciﬁc methylation and expression are conserved among the members of the PLG gene family. (A) PLG gene and its variants display a high homology of sequence as
evidenced by the genomic sequence alignment of the PLG, PLGLA, PLGLB1 and PLGLB2 5′ regions. Sequences analyzed by bisulﬁte sequencing are underlined. Red rectangles highlight
the mismatches between the aligned sequences. (B) DNA methylation analysis for PLG in human adult skeletal muscle, heart muscle, and liver. Samples are displayed column-wise
with rows representing individual CpG's of the PCR fragment. Quantitative methylation analysis results are shown in a color scale ranging from yellow (≈0% methylation), to green
(≈50% methylation), to dark blue (≈100% methylation). (C) Mosaic distribution of DNA methylation in PLG, PLGLA, and PLGLB in liver. CpG sites in the subcloned PCR products were
either all methylated or all unmethylated. Numbers indicate the position of each CpG relative to the corresponding transcription start site (TSS) (Ensembl NCBI 40). Filled and empty
circles represent methylated and unmethylated CpG's, respectively. Dashed circles indicate CpG positions lost due either to sequence polymorphism (in the PLG gene) or to sequence
mismatches with PLG (PLGLA and PLGLB genes). Alleles were identiﬁed by an annotated SNP (rs4252059) within the ampliﬁed sequence for PLG or the equivalent polymorphism in
PLGLA and PLGLB. (D) Expression of PLG in human heart muscle, liver, and skeletal muscle. Results of RT-PCR show that gene silencing correlates with 5′-UTR hypermethylation of
PLG. Similar amounts of cDNAwere used as indicated by control ampliﬁcation of actin β (ACTB). Representative results for three independent samples are shown. Total RNAs derived
frommixed tissues and cell lines were used as positive control. (E) Biallelic expression of PLG. Biallelic expression was analyzed by sequencing the ampliﬁed cDNA and identiﬁcation
of a heterozygous annotated SNP (red arrow, SNP rs1136056). Presence of both alleles in the sequenced cDNA indicates biallelic expression.
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Fig. 1 (continued).
494 R. Cortese et al. / Genomics 91 (2008) 492–502activation, the proteolytic plasmin digests the insoluble ﬁbrin clot,
playing a key role in tissue repair and wound healing. However, the
functions of PLGLA, PLGLB1 and PLGLB2 remain largely elusive.
Results
DNA methylation and expression of PLG gene family members
As part of a chromosome-wide methylation proﬁling study, we
recently obtained the methylation proﬁle of PLG [4]. In that study, we
found that the 5′-UTR of PLG is differentially methylated in healthy
tissues, with skeletal and heart muscle being 100% methylated and
liver being only 50% methylated (Fig. 1B).Comparative sequence analysis of human PLG showed a high
homology to three members of the PLG gene family (Fig. 1A). The PLGLA
gene (ENSG00000169659) is locatedon chromosome2q12.2 anddisplays
a 95.8% homologywith the PLG gene in its 5′ region and exon 1. Similarly,
PLGLB1 (ENSG00000125551) and PLGLB2 (ENSG00000183281) are
located on chromosome 2p11.2 and 2p11-q11, respectively, with DNA
sequence homology in the 5′ region to PLG of about 95 and 96%,
respectively.
We examined, if the differential methylation observed in the 5′-UTR
of PLG is conserved in these genes and if the cognate mRNA expression
patterns display an inverse correlation with the respective promoter
methylation that would point to a conserved regulatory control of
expression by DNA methylation. To this end, we used several sequence
Fig. 2.Methylation proﬁling of TBX gene family members. (A) Methylation proﬁles of 15 genes of the TBX transcription factor family and their evolutionary relationships are shown.
The 15 genes are from four subfamilies (Tbr1 subfamily, TBX21, EOMES, TBR1; Tbx1 subfamily, TBX1, TBX10, TBX15, TBX18, TBX20, and TBX22; Tbx2 subfamily, TBX2, TBX3, TBX4, and
TBX5; Tbx6 subfamily, MGA and TBX6). Closely related TBX genes display complementary methylation proﬁles (e.g., TBX1/TBX10 and TBX2/TBX3). The evolutionarily more distant
MGA and TBR1 are not differentially methylated in the tissues examined. The methylation values are color coded as in Fig. 1. Phylogenetic relationships within the TBX family
were previously described in [34]. (B) Gender-speciﬁc methylation in the TBX22 gene located on chromosome X. TBX22 is approx 50% methylated in liver samples derived from
female donors and approx 0% in male-derived liver samples. The methylation values are color coded as in Fig. 1.
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Table 1
Methylation values for pseudogenes and their respective parental genes
Pseudogene Sample 1 methylationa Sample 2 methylation Parental gene Sample 1 methylation Sample 2 methylation Sequence homology Type pseudogene
AP000357.2 100% 0% ACTR2 100% 100% 57.10% Processed
AP000357.3 100% 25% ARL5A 0% 0% 92.30% Processed
RP11-758C21.1 100% 50% BDH2 100% 100% 96.60% Processed
RP1-181C9.1 100% 25% ANP32B 0% 0% 71.40% Processed
AP000358.2 100% 25% FN3K 100% 50% 87.70% Processed
CTA-229A8.2 100% 50% GAPDH 50% 50% 62.50% Processed
AC007050.7 100% 100% POM121L3 100% 100% 96.80% Processed
RP3-412A9.4 100% 50% SNRPN 100% 100% 88.10% Processed
KB-1269D1.3 100% 25% MAD1L1 100% 75% 95.10% Processed
AC000078.2 100% 25% RPL8 100% 75% 65.90% Processed
AC004019.3 100% 50% LOC376522 75% 50% 84.00% Processed
CTA-373H7.4 100% 0% HBLD1 0% 0% 99.50% Processed
CTA-373H7.4 100% 0% HBLD1 75% 75% 75.80% Processed
RP1-47A17.8 100% 25% ADAMTS7 100% 100% 84.50% Processed
RP1-106I20.2 100% 100% NDUFA9 100% 100% 94.10% Processed
AC004471.4 100% 100% NM_032028.2 100% 100% 82.80% Processed
RP3-405J24.1 100% 100% RPL12 100% 50% 92.20% Processed
CTA-150C2.8 100% 50% APOBEC3G 100% 100% 64.30% Unprocessed
CTA-246H3.2 0% 0% LRP5 0% 0% 89.10% Unprocessed
RP4-539M6.7 100% 25% SLC39A1 100% 25% 84.80% Unprocessed
KB-1592A4.6 100% 100% BCR 100% 100% 97.20% Unprocessed
LL22NC03-31F3.7 100% 50% Q6UW61_HUMAN 100% 50% 94.40% Unprocessed
RP11-34P13.1 100% 100% DDX11 75% 75% 71.30% Unprocessed
RP11-223J15.2 100% 100% EEF1A2 50% 50% 64.30% Unprocessed
RP4-732G19.2 100% 100% CYP4Z1 100% 100% 88.80% Unprocessed
RP11-552J9.1 100% 100% XAGE2 100% 100% 72.60% Unprocessed
BMS1LP6 100% 100% BMS1L 100% 100% 89.10% Unprocessed
CTSLL3 75% 75% CTSL 75% 75% 89.30% Unprocessed
RP11-432I13.3 75% 100% CUBN 100% 75% 89.40% Unprocessed
RP11-453N3.6 75% 75% ABCD1 75% 75% 95.40% Unprocessed
RP11-392A23.3 50% 50% GSTA1 100% 100% 83.70% Unprocessed
NM_002688.4 0% 100% SEPT5 0% 0% 53.50% Unprocessed
aDNA methylation values corresponding to two paired samples, being tissues (liver, skeletal muscle, and heart muscle) or primary cell lines (keratinocytes, ﬁbroblasts, melanocytes,
and CD4+ lymphocytes), per parental gene–pseudogene pair are shown. The selection was based on pseudogenes, for which we had previously detected tissue-speciﬁc methylation
[4]. The values shown are the medians of all CpG positions within the PCR fragment rounded to 0, 25, 50, 75, and 100%.
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gene and the identity of the expressed transcripts. However, because
PLGLB1 and PLGLB2 differ by only one mismatch in the coding region
(data not shown), we could not assess differences in methylation and
mRNA expression between these two genes.
We analyzed the conservation ofDNAmethylation in humanPLG and
the PLGLA and PLGLB1/B2 genes by sequencing of subcloned PCR
amplicons derived from bisulﬁte-treated DNA obtained from healthy
adult skeletal muscle, heart muscle, and liver. This approach revealed
that in liver samples, the DNAmethylation of all PLG genes (PLG, PLGLA,
and PLGLB1/B2) is distributed in a mosaic manner (Figs. 1B and C), with
all CpG's contained in the same clone being either methylated or
unmethylated. In contrast, DNA derived from heart muscle or skeletal
muscle displayed a homogeneousmethylation for all clones (Fig.1B and
data not shown). Methylation of PLG clones did not segregate with an
annotated SNP in this region (rs4252059), indicating that this gene is not
allele-speciﬁcally methylated. Similarly, we found heterozygous poly-
morphisms in the sequences corresponding to PLGLA and PLGLB
subclones, pointing to a biallelic methylation of both variants.
Expression analysis by RT-PCR for PLG revealed that the 5′-UTR
methylation of this gene is inversely correlated with its expression
(Fig. 1D). In tissues (heart muscle and skeletal muscle) that displayed a
completely methylated PLG 5′-UTR we detected no PLG mRNA expres-
sion, while in liver, the respective 5′-UTR was only 50% methylated
and PLGwas expressed. Subsequent sequencing of the obtained RT-PCR
product revealed the presence of a heterozygous SNP (rs1136056), in-
dicating that PLG, similar to the biallelic methylation of its 5′-UTR, is
biallelically expressed as well (Fig. 1E). To study the expression of the
other PLG genes, we designed a RT-PCR fragment that allowed for
the unbiased ampliﬁcation of the three transcripts. Primers for this
fragment bound to regions containing no mismatches between PLG,PLGLA, and PLGLB transcripts, whereas the ampliﬁed region contained
nine mismatches that allowed the identiﬁcation of the expressed gene.
Similar to PLG (Fig. 1E), PLGLA and PLGLB1/PLGLB2were expressed only in
liver, not in skeletal or heart muscle (data not shown), indicating a DNA
methylation-dependent regulation similar to that of PLG.
Differential DNA methylation in the TBX family
In contrast to the PLG gene duplicates that arose recently in the
hominoid lineage, the TBX family arose early during evolution and is
present in vertebrates, invertebrates, and protostomes (e.g.,Drosophila
melanogaster and Caenorhabditis elegans). To examine further the
methylation proﬁles in this large gene family we selected 15 genes
from four subfamilies (Tbr1 subfamily, TBX21, EOMES, and TBR1; Tbx1
subfamily, TBX1, TBX10, TBX22, TBX18, TBX15, and TBX20; Tbx2
subfamily, TBX2, TBX3, TBX4, and TBX5; Tbx6 subfamily, MGA and
TBX6) and performed DNA methylation proﬁling of their 5′-UTRs in
eight different tissues and primary cells (Fig. 2A). Most of the genes
and tissues were unmethylated, with TBX10 being themost prominent
exception. Of these genes, 7 (TBX10, TBX1, TBX18, TBX15, TBX4, TBX5,
and TBX21) were differentially methylated in at least one of the
tissues, but none of the genes showed an identical methylation
pattern (Fig. 2A). In particular, differential methylation was evident in
genes displaying a shorter evolutionary distance. For example, TBX1
was hypermethylated in melanocytes, ﬁbroblasts, and skeletal
muscle, while being unmethylated in the remaining tissues. The
closely related TBX10 gene was hypermethylated in most of the
tissues, but four CpG's, 93, 104, 119, and 139 bp upstream from the
TSS, were unmethylated. Similarly, genes of the Tbx2 subfamily were
differentially methylated as well. For TBX22, which is located on the
X chromosome, we observed no tissue-speciﬁc methylation, but did
Fig. 3. Conservation of tissue-speciﬁc methylation in an unprocessed pseudogene–parental gene pair. (A and B) The TDMR of the unprocessed pseudogene KB-1995A5.12 (A) is
conserved in its parental gene Q6UW61_HUMAN (B). The positions of the analyzed regions are shown. Liver samples are hypermethylated in both regions, while skeletal muscle
samples display a 50%methylation. Rows represent individual samples with columns representing individual CpG's of the PCR fragment. Quantitativemethylation analysis results are
shown in a color scale ranging from yellow (≈0% methylation), to green (≈50% methylation), to dark blue (≈100% methylation).
497R. Cortese et al. / Genomics 91 (2008) 492–502observe sex-speciﬁc methylation, with approx 50% methylation in
samples derived from female donors and approx 0% methylation in
male-derived samples (Fig. 2B). Genes such asMGA and TBR1, that are
more distant from other family members, displayed no differential
methylation.
DNA methylation in pseudogenes
To study further the fate of DNA methylation upon gene duplica-
tion, we examined the methylation proﬁles of processed and unpro-
cessed pseudogenes. We selected putative parental gene–pseudogenepairs according to their annotation in the Vertebrate Genome An-
notation Database (Vega) [16] and studied the respective DNA
methylation in regions of highest sequence homology. In total, we
selected 17 processed and 15 unprocessed pseudogenes for whichwe
had previously obtained methylation proﬁles [4] and analyzed the
DNA methylation of their respective parental genes. Respective
pseudogenes were selected if they displayed tissue-speciﬁc differ-
ential methylation in at least one tissue analyzed. As controls, we
included pseudogenes showing homogeneous hypermethylation
(N80%) or unmethylation (b20%) in the analyzed tissues. For each
pseudogene–parental gene pair, we obtained methylation proﬁles
Fig. 4. Tissue-speciﬁc methylation is not conserved in processed pseudogene–parental gene pairs. (A and B) The TDMR located within the processed pseudogene AP000357.3 (A) is
not conserved in its parental gene ARL5A (B). The processed pseudogene is unmethylated (b20%) in ﬁbroblasts and hypermethylated (N80%) in keratinocytes. In contrast, the parental
gene is unmethylated in both cell types. Methylation values are shown as in Fig. 3.
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muscle, and heart muscle) or primary cell lines (keratinocytes,
ﬁbroblasts, melanocytes, CD4+ lymphocytes). Table 1 summarizes the
observed methylation values and the homology between the loci
used to measure DNA methylation of pseudogene–parental gene
pairs.
Unprocessed pseudogenes
Among the 15 unprocessed pseudogenes analyzed, 5 (33%) sho-
wed tissue-speciﬁc methylation in at least one examined tissue. For 2pseudogenes, RP4-539 M6.7 and LL22NC03-31F3.1, this differen-
tial methylation was conserved in the respective parental genes,
SLC39A1 and Q6UW61_HUMAN. Six (40%) unprocessed pseudoge-
nes and their respective parental genes were hypermethylated in
both tissues, while 1 (7%) pseudogene–parental gene pair was un-
methylated in the analyzed tissues. The remaining 3 unprocessed
pseudogenes (20%) and their respective parental genes displayed
heterogeneous methylation values ranging from 25 to 75%. In no case
did we ﬁnd a parental gene displaying tissue-speciﬁc methylation,
while the respective unprocessed pseudogene had lost the differential
Fig. 5. DNA distances and DNAmethylation in duplicated sequences. (A) Examples of DNA distances between gene variants and pseudogene–parental gene pairs. DNA distances were
calculated using the PHYLIP software and results are represented as a radial tree for each gene pair. The distance between the internal node and the duplicated gene or pseudogene is
indicative of the evolutionary distance to the parental gene. Examples of distances from the internal node are shown for the PLG variants (0.0313 and 0.0209, for PLGLA and PLGLB,
respectively) and the TBX1/TBX10 pair (top) and unprocessed (0.0183) and processed pseudogenes (0.0856; bottom). The DNA distance observed for TBX1/TBX10 (0.2346) is about 10
times larger than those observed in the PLG family. (B) Relationship between tissue-speciﬁc methylation conservation and DNA distance in gene families and unprocessed and
processed pseudogenes. For the TBX family, the representative TBX1/TBX10 pair is shown. Pairs displaying conservation of methylation are among those showing the shorter
distances. Since some parental gene–pseudogene pairs displayed identical DNA distances, only 13 points (of 15) corresponding to unprocessed pseudogenes and only 15 (of 17)
processed pseudogenes are shown. (C) DNA methylation transitions in gene duplications. The methylation proﬁles from the parental genes were compared to the respective gene
variants and pseudogenes. If the methylation differed by less than 20% in the same tissue, the methylation of the respective parental gene/pseudogene pair was considered to be
unchanged. Many of the parental genes displayed the same methylation values compared to their respective pseudogenes in each individual tissue. Hypermethylated processed
pseudogenes exhibited larger DNA distances to the parental genes than unmethylated processed genes. y axis: DNA distances to the internal node calculated by PHYLIP.
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processed pseudogene (KB-1995A5.12, Fig. 3A) and its correspond-
ing parental gene (Q6UW61_HUMAN, Fig. 3B). The TDMR located in
the 5′ region of this unprocessed pseudogene displayed a very high
sequence homology (N94%) with a region in intron 2 of the parental
gene. This high sequence homology extended to other regions of this
gene pair, e.g., exon 3 of Q6UW61_HUMAN was similarly homologous
to exon 1 of KB-1995A5.12, suggesting that some truncation occurred
during or after the duplication event. Similarly, analysis of the 5′-UTR
of the unprocessed pseudogene RP4-539M6.7 and the respective
homologous region of its parental gene SLC39A1 displayed as well a
conservation of the tissue-speciﬁc methylation (Table 1 and data
not shown). Expression analysis by RT-PCR for these two parentalgene–pseudogene pairs revealed no correlation between the
methylation status of a gene and its expression. The parental gene
Q6UW61_HUMAN and its unprocessed pseudogene were expressed
in all examined tissues. In contrast, SLC39A1was expressed in all the
studied tissues, while no transcript was found for its unprocessed
pseudogene (data not shown).
Processed pseudogenes
Among the 17 analyzed processed pseudogenes, 13 (76%) displa-
yed tissue-speciﬁc methylation in at least one of the tissues analyzed,
while 4 (24%) were hypermethylated in all tissues (Table 1). In contrast
to the unprocessed pseudogenes, we did not ﬁnd a conservation of tissue-
speciﬁcmethylationbetween anyof the analyzedprocessed pseudogene–
500 R. Cortese et al. / Genomics 91 (2008) 492–502parental gene pairs. Fig. 4 shows an example of the tissue-speciﬁc
methylation of a processed pseudogene (AP000357.3, Fig. 4A) and the
methylation proﬁle of the respective homologous region in the
parental gene ARL5A (Fig. 4B). The TDMR of the pseudogene
displayed an average methylation in dermal ﬁbroblasts and kerati-
nocytes of 25 and 90%, respectively. Such differential methylation
was not observed for the parental gene ARL5A (Fig. 4B), despite the
high sequence homology of both analyzed sequences (92%). Four
processed pseudogenes displayed homogeneous hypermethylation
in the analyzed tissues. Among them, three of the respective parental
genes were similarly hypermethylated in the same samples,
POM121L3, NDUFA9, and NM_032028.2, corresponding to
AC007050.7, RP1-106I20.2, and AC004471.4, respectively (Table 1).
For only one gene (RPL12) did we ﬁnd a TDMR in the parental gene
that was lost in its cognate processed pseudogene, RP3-405J24, being
hypermethylated in both tissues.
Comparative analysis
To analyze further the evolutionary relationship between the pseu-
dogene–parental gene pairs and its relation to the observed methyla-
tion proﬁles, we calculated their evolutionary distance by assuming
that each base in the DNA sequence has an equal chance of mutating
(Jukes-Cantor model [17]). Using the chimpanzee orthologue of the
parental gene as an outgroup, DNA distance matrices were computed
for each pair. To minimize any bias introduced by the selection of
promoter vs coding regions we used only putative coding regions to
calculate the distance and included only conﬁrmed human–chimpan-
zee orthologues (as retrieved from the Ensembl database). Fig. 5A
shows examples of the calculated DNAdistances for the PLG family, the
TBX1/TBX10 gene pair, and pairs of parental genes with processed or
unprocessed pseudogenes, respectively. DNA distances between the
PLG gene and other PLG family genes showed similar distances for
PLGLA (0.0313) and PLGLB1/B2 (0.0209). As PLGLB orthologues exist in
chimpanzee (Pan troglodytes) but not in Old World monkey (Macaca
mulatta) and within the Eutheria infraclass, we estimate that the PLG
duplication occurred after the hominid–cercopithecoid divergence,
some 29–35 million years ago [18]. In contrast, the evolutionary
distance of the TBX1 and TBX10 pair (0.2346) is about 10 times larger
than that observed for PLG and these genes are present as well in other
mammals, such as mice, indicating that this duplication occurred at
least 80–130 million years ago [19].
Next, we analyzed the conservation of DNA methylation in each
tissue and its dependency on the evolutionary distance for the PLG
gene family, the TBX1/TBX10 pair, and the pseudogene–parental gene
pairs (Fig. 5B). In this analysis, conserved methylation was assigned if
the methylation values from the respective gene pair differed by less
than 20% between measurements of the same tissues. For both,
unprocessed and processed pseudogenes, we observed a lack of
methylation conservation for most of the tissues and pseudogenes
examined. This lack of conserved methylation was evident as well for
pseudogene–parental gene pairs that arose fairly recently as evidenced
by a short evolutionary distance (Fig. 5B). Conserved TDMRs were
observed for only two unprocessed pseudogene–parental gene pairs
(see above) and for the PLG gene family. Notably, these genes displayed
a rather short evolutionary distance of 0.1258 for the RP4-539M6.7–
SLC39A1 and 0.0183 for the LL22NC03-31F3.7–Q6UW61_HUMAN pair.
As well, we analyzed if pseudogenes are preferentially hypermethy-
lated or hypomethylated compared to their parental genes but found
no evidence that the analyzed pseudogenes became persistently hy-
permethylated (Fig. 5C). We found pseudogenes that were both
hypomethylated and hypermethylated compared to the cognate
parental gene. Although the analyzed number of gene pairs is too
small to generalize our observation, we observed a trend indicating
that hypermethylated processed pseudogenes were evolutionarily
more distant from their parental genes than unmethylated processed
pseudogenes.Discussion
The mechanisms and signals that lead to tissue-speciﬁc methyla-
tion are currently not known. Here, we have analyzed the fate of
TDMRs in gene duplication events. For the functional PLG gene family,
the TDMRs are conserved in all known members, independent of the
genomic location of each gene. For all PLG genes, the methylation
status of the TDMR is inversely correlated with the respective gene
expression, suggesting that the functions of these TDMRs are
conserved as well. Similarly, we found conserved TDMRs in two gene
duplication events leading to unprocessed pseudogenes. Although
more gene familieswill have to be tested to generalize our observation,
these results suggest that the sequence itself might contain the signal
conferring tissue-speciﬁc methylation independent of the genomic
location. A possibility we currently cannot rule out is that the
differential methylation of, e.g., PLGLA and PLGLB1/B2 arose indepen-
dently and reoccurred after gene duplication.
The TDMRs observed in the TBX family, and the vast majority of
TDMRs found in both unprocessed and processed pseudogenes, are
not conserved, suggesting that other mechanisms leading to TDMRs
must exist as well. Possibly, once the gene duplication is transmitted
through the germ line, DNA methylation associated with, e.g., tissue
development may override the existing methylation mark of the dup-
licated gene and thereby generate a new methylation proﬁle for
this gene. We have observed a bias for recently evolved processed
pseudogenes being rather unmethylated compared to more distant
processed pseudogenes. This ﬁnding, if conﬁrmed by a larger gene
panel, may indicate that newly processed pseudogenes become prefe-
rentially integrated into open chromatin structures that are generally
associated with unmethylated DNA. A similar bias has been repor-
ted for retroviruses such as the human immunodeﬁciency virus that
preferentially integrate in open chromatin structures [20].
The function of TDMRs located within pseudogenes is not known.
They could be nonfunctional evolutionary relics of abortive gene dup-
lications but may as well confer stage- and tissue-speciﬁc expression
of pseudogenes. Some pseudogenes, although not coding for a func-
tional protein, are transcribed and have a regulatory function [21]. A
prominent example is theXist gene, a key regulator for X-chromosomal
inactivation that arose by pseudogenization of a protein-coding gene
[22]. Other pseudogenes, such as the NOS [23] and the Markorin [24]
pseudogenes, regulate expression of their respective parental genes,
although some results have been disputed by others [25].
Rodin and Riggs [26] proposed an epigenetic complementation
model to predict the fate of gene duplicates. In this model, stage-
and tissue-speciﬁc epigenetic silencing/activation helps to maintain
negative selection on both copies of the duplicated gene. This
epigenetic complementation would thus lead to a complementary
expression of the original gene and its twin copy, and consequently,
complementary gene expression would expose both copies to a
purifying selection and may prevent degradation into a pseudogene.
In this aspect, it is of interest to note that the methylation proﬁles
observed for the functional TBX gene family were very gene-speciﬁc
and each gene had a distinct methylation proﬁle. In this study, we
have analyzed a limited number of different tissues and cells and it is
likely that a more comprehensive analysis would reveal further
speciﬁc TDMR proﬁles. For example, we have recently shown that
TBX21 is speciﬁcally unmethylated in CD4+ Th1 and CD8+ memory
lymphocytes but not in CD4+ and CD8+ naïve lymphocytes [27]. In
contrast, the very recently evolved PLG family members displayed
similar expression and methylation proﬁles that may indicate that
some PLG paralogues are destined to pseudogenization. Alterna-
tively, if PLGLA, PLGLB1 and PLGLB2 are functionally different
compared to PLG, it is possible that these genes escaped pseudo-
genization by a neofunctionalization event and may share the
epigenetic regulatory mechanism due to their high sequence
homology. More comprehensive DNA methylation proﬁling studies
501R. Cortese et al. / Genomics 91 (2008) 492–502are needed to understand further the dynamics of DNA methylation
in genome evolution and gene duplications.
Materials and methods
Tissue samples
DNA used for methylation analysis was isolated from human tissue samples (hu-
man heart, liver, and skeletal muscle) and primary cell cultures (melanocytes, ﬁbro-
blasts, keratinocytes, and CD4+ lymphocytes). Human tissue samples were acquired
from commercial suppliers: Asterand (Detroit, MI, USA), Pathlore Plc. (Nottingham, UK),
Tissue Transformation Technologies (T-Cubed, Edison, NJ, USA), Northwest Andrology
(Missoula, MT, USA), NDRI (Philadelphia, PA, USA), and BioCat GmbH (Heidelberg,
Germany). Primary cells were purchased from Cascade Biologics (Mansﬁeld, UK), Cell
Applications (San Diego, CA, USA), Analytical Biological Services (Wilmington, DE, USA),
Cambrex Bio Science (Verviers, Belgium), and DIGZ (Berlin, Germany) and were cultu-
red for a maximum of three passages according to the supplier's recommendations. For
correlative studies, matched total RNA/DNA samples (heart muscle, skeletal muscle,
liver) were purchased from BioCat GmbH. In all cases, only anonymous samples were
used and ethical approval was obtained for the study. Mouse DNA from liver, heart, and
skeletal muscle was acquired from BioCat GmbH.
DNA extraction and PCR ampliﬁcation
DNAwas extracted using the DNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer's recommendations. For DNA methylation analysis, DNA was bisulﬁte
converted and PCR ampliﬁed as previously described [28]. Bisulﬁte-speciﬁc primers
with a minimum length of 18 bp were designed using a modiﬁed Primer3 program.
The target sequence of the designed primers contained no CpG's, allowing an unbiased
ampliﬁcation of both hypomethylated and hypermethylated DNAs. Primers were also
tested for speciﬁcity by electronic PCR.Methylationproﬁles of the 5′-UTRs of PLG, PLGLA,
and PLGLB1/B2 were analyzed by unbiased, simultaneous ampliﬁcation of these genes.
Subsequent subcloning of the PCR fragment and sequencing allowed the identiﬁca-
tion of the speciﬁc gene by the identiﬁcation of several sequence mismatches (Fig. 2A).
Sequence mismatches were conﬁrmed by sequencing of genomic DNA as well.
Genomic DNA ampliﬁcationwas carried out using the HotStartTaq DNA polymerase
kit (Qiagen) with 10 ng of genomic DNA and gene-speciﬁc primers. Primers for geno-
mic DNA ampliﬁcation were designed using the Primer3 software [29]. Ampliﬁcation
conditions for the genomic DNA were 15 min at 95 °C followed by 40 cycles of 92 °C
for 60 s, 72 °C for 60 s, and 72 °C for 60 s and a ﬁnal extension step of 10 min at 72 °C.
Genomic PCR fragments used for the genotyping of the matched DNA/RNA samples
contained at least one reported SNP.
RNA extraction and RT-PCR
In all cases, tissue and cell samples were kept at -80 °C prior to RNA isolation and
isolated RNAs were stored at -80 °C until further use. Total RNA was isolated with the
RNeasy kit (Qiagen) followed by cDNA synthesis using the Omniscript RT kit from the
same supplier and random hexamers. PCR (92 °C for 1 min, 60 °C for 1 min, 72 °C for
1 min for 40 cycles) was performed using the HotStartTaq DNA polymerase kit (Qiagen)
with 3 µl of the prepared cDNA and gene-speciﬁc primers. All kits were used accord-
ing to the manufacturer's recommendations. PCR products were analyzed by electro-
phoresis on 2.5% agarose gels. All RT-PCR fragmentswere designed spanning at least one
intron to avoid ampliﬁcation of contaminating genomic DNA. Universal RNA (BioCat)
was used as positive control. RT-PCR fragments used to determine allelic expression
contained at least one reported SNP.
As for the bisulﬁte-treated DNA, a unique primer pair was used to study the ex-
pression of PLG, PLGLA, and PLGLB1/B2. Primers bound to sequences showing no mis-
matches between the transcripts, while the ampliﬁed region contained several
mismatches that allowed their identiﬁcation after direct sequencing.
Sequencing
PCR amplicons from bisulﬁte-treated and genomic DNA, as well as RT-PCR products,
were quality controlled by agarose gel electrophoresis, puriﬁed with ExoSAP-IT (USB
Corp., Cleveland, OH, USA) to remove any excess nucleotides and primers, and se-
quenced directly in forward and reverse directions. Alternatively, the resultant PCR
and RT-PCR products were cloned into a TA-cloning plasmid according to the ma-
nufacturer's instruction (pGEM T-Easy Cloning Kit; Promega, Madison, WI, USA) and
DNA was isolated using a Qiaprep Spin Plasmid Miniprep Kit (Qiagen) according to the
manufacturer's instructions. All PCR fragments and plasmids were sequenced in for-
ward and reverse directions. Sequencing was performed on an ABI 3730 capillary
sequencer using a 1/20 dilution of ABI Prism BigDye Terminator v3.1 sequencing che-
mistry after hot-start (96 °C for 30 s) thermocycling (92 °C for 5 s, 50 °C for 5 s, 60 °C
for 120 s×44 cycles). Before injection, products were puriﬁed on DyeEx plates (Qiagen).
PCR and RT-PCR fragments were sequenced directly with the same primers as in the
PCR reaction, while M13 primers (M13-F, TGTAAAACGACGGCCAGT; M13-R, CAGGAAA-
CAGCTATGACC) were used to sequence the cloned PCR products. The obtained se-
quencing chromatograms were used to quantify the methylation at a given CpG aspreviously described [4,30,31]. The software used for the analysis of all loci descri-
bed herein is freely available at www.epigenome.org. Samples and expressed alleles
were genotyped by identiﬁcation of annotated SNPs in the trace ﬁles.
Analysis and statistical methods
Differential methylation in direct bisulﬁte sequencing experiments was deter-
mined by the Wilcoxon rank sum test [32]. DNA distance matrices and radial trees
were constructed with the PHYLIP software package [33]. Distances between the
internal node and the pseudogene sequence d(HΨ,IN) were computed according to d
(HΨ,IN)= [d(H,HΨ)+d(HΨ,C) - d(H,C)]/2, where d(H,HΨ) is the distance between the
parental gene and the pseudogene sequences, d(HΨ,C) is the distance between the
pseudogene and the chimpanzee gene sequences, and d(H,C) the distance between
the human and the chimpanzee gene sequences, as obtained in the DNA distance
matrix for each gene group. To determine whether methylation values were
conserved between parental and derivative sequences, we assigned the methylation
values in two tissues per pair, where differential methylation of the pseudogene was
previously detected [4]. We binned the obtained methylation values to 0, 25, 50, 75,
and 100%, as shown in Table 1. Pairs displaying methylation differences lower than
25% were considered unchanged.
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